MAPK8, mitogen-activated protein kinase 8, 5599

N. diseases: 520; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0017160
Disease: Gastroenteritis
Gastroenteritis
0.010 AlteredExpression disease BEFREE We specifically identified p38 and JNK1, which are the downstream molecules of receptor tyrosine kinases (RTKs) required for efficient TGEV replication, as A9 targets through plaque assays, qRT-PCR and Western blotting assays. p38 and JNK1 inhibitors and RNA interference further showed that the inhibitory activity of A9 against TGEV infection was mainly mediated by the p38 mitogen-activated protein kinase (MAPK) signaling pathway. 31751591 2020
CUI: C1261473
Disease: Sarcoma
Sarcoma
0.010 AlteredExpression group BEFREE Our results documented that X-rays could induce ER stress in sarcoma and then autophagy was activated by unfolded protein response (UPR) through the IRE1-JNK-pBcl2-Beclin1 signaling axis. 31785812 2020
CUI: C1800706
Disease: Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
0.010 Biomarker disease BEFREE Using IPF mouse models, lung fibroblasts for the experiments were treated with miR-448 mimic, miR-448 inhibitor, si-ABCC3, or SP600125 (inhibitor of JNK) to evaluate the cell proliferation and apoptosis in response to miR-448. 31506947 2020
CUI: C4551686
Disease: Malignant neoplasm of soft tissue
Malignant neoplasm of soft tissue
0.010 AlteredExpression group BEFREE Our results documented that X-rays could induce ER stress in sarcoma and then autophagy was activated by unfolded protein response (UPR) through the IRE1-JNK-pBcl2-Beclin1 signaling axis. 31785812 2020
CUI: C0001973
Disease: Alcoholic Intoxication, Chronic
Alcoholic Intoxication, Chronic
0.010 PosttranslationalModification disease BEFREE Dysregulation of c-Jun N-terminal kinase phosphorylation in alcohol dependence. 30321699 2019
CUI: C0004763
Disease: Barrett Esophagus
Barrett Esophagus
0.010 AlteredExpression disease BEFREE Genes regulated by the TGFB and JNK pathway were overexpressed specifically in EAC and dysplastic BE. 30768984 2019
CUI: C0005944
Disease: Metabolic Bone Disorder
Metabolic Bone Disorder
0.010 Biomarker group BEFREE An important osteoclastogenesis-regulating signaling pathway (JNK1-Bcl-2-Beclin1-autophagy activation) was identified, which provides novel potential targets for the clinical therapy of metabolic bone diseases.-Ke, D., Ji, L., Wang, Y., Fu, X., Chen, J., Wang, F., Zhao, D., Xue, Y., Lan, X., Hou, J. JNK1 regulates RANKL-induced osteoclastogenesis <i>via</i> activation of a novel Bcl-2-Beclin1-autophagy pathway. 31295022 2019
CUI: C0006845
Disease: Candidiasis, Chronic Mucocutaneous
Candidiasis, Chronic Mucocutaneous
0.010 Biomarker disease BEFREE Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β. 31784499 2019
CUI: C0007115
Disease: Malignant neoplasm of thyroid
Malignant neoplasm of thyroid
0.010 Biomarker disease BEFREE Taken together, our data suggest that Mst1 activation and Yap inhibition coordinate to augment thyroid cancer cell death by controlling the JNK-MIEF1-mitochondria pathway, suggesting that differential regulation of the core Hippo pathway components is potentially a novel therapeutic tool for the treatment of thyroid cancer. 31139020 2019
CUI: C0007682
Disease: CNS disorder
CNS disorder
0.010 Biomarker group BEFREE Taken together, our data first proved the pro-inflammatory function of ATF2 in microglia, and suggested that the TRAF6-JNK/p38-ATF2 axis might promote microglial inflammatory activation and thus aggravate neuronal injury in brain, which might become a potential therapeutic target for CNS diseases. 30763583 2019
CUI: C0008055
Disease: Chikungunya Fever
Chikungunya Fever
0.010 Biomarker disease BEFREE A strong polar interaction was predicted between Thr-180 (within the phosphorylation lip) of p38 and Gln-273 of nsP2, whereas, no such polar interaction was predicted for the phosphorylation lip of JNK which indicates the differential roles of p-p38 and p-JNK during CHIKV infection in the host macrophages. 31031770 2019
CUI: C0009766
Disease: Allergic Conjunctivitis
Allergic Conjunctivitis
0.010 AlteredExpression disease BEFREE Additionally, the ANXA1<sub>2-26</sub>-Fpr system in the AC was associated with the activation of ERK and JNK. 30419240 2019
CUI: C0009782
Disease: Connective Tissue Diseases
Connective Tissue Diseases
0.010 Biomarker group BEFREE Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-β. 31784499 2019
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.010 AlteredExpression disease BEFREE Compared to HC, active CD plasma decreased ZO-1 and OCCLUDIN expression on mRNA and protein levels, and led to an increased JNK phosphorylation. 30765731 2019
CUI: C0011195
Disease: Dejerine-Sottas Disease (disorder)
Dejerine-Sottas Disease (disorder)
0.010 Biomarker disease BEFREE Analysis of inflammatory signalling pathways indicated robust activation and expression of NF-κB/c-Jun/MAPKs (JNK and p38) in DSS treated animal which was strongly abrogated by BLFE treatment. 31620885 2019
Diabetes Mellitus, Insulin-Dependent
0.010 Biomarker disease BEFREE We examined contributions of inflammatory molecules lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), stress-activated kinases (c-Jun N-terminal kinase [JNK] and p38), arginase, and reactive oxygen species to coronary arteriolar dysfunction in a porcine model of type 1 diabetes. 31015037 2019
Disseminated Intravascular Coagulation
0.010 Biomarker disease BEFREE Furthermore, a JNK inhibitor (SP600125) and ERK inhibitor (SCH772984) partially protected mice against PAF-induced death, whereas a p38 MAP-kinase inhibitor (SB203580) provided complete protection against DIC and death. 31442556 2019
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.010 Biomarker disease BEFREE To achieve this goal, we used JNK-knockout mice (Jnk1<sup>-/-</sup>, Jnk2<sup>-/-</sup>, and Jnk3<sup>-/-</sup>), untreated and treated with intraperitoneal injections of kainic acid (KA), as an experimental model of epilepsy. 30685843 2019
CUI: C0014859
Disease: Esophageal Neoplasms
Esophageal Neoplasms
0.010 Biomarker group BEFREE Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer. 30768984 2019
CUI: C0016053
Disease: Fibromyalgia
Fibromyalgia
0.010 AlteredExpression disease BEFREE Effect of transcutaneous electrical acupuncture point stimulation on expression of p-JNK in the dorsal root ganglion in a rat model of myofascial pain syndrome. 31219313 2019
CUI: C0018378
Disease: Guillain-Barre Syndrome
Guillain-Barre Syndrome
0.010 AlteredExpression disease BEFREE GBS infection increased levels of total and phosphorylated mitogen-activated protein kinase (MAPK) family members such as p38 and JNK and induced nuclear factor kappa B (NF-κB) pathway activation. 31548323 2019
CUI: C0021051
Disease: Immunologic Deficiency Syndromes
Immunologic Deficiency Syndromes
0.010 AlteredExpression group BEFREE Tai-expressing cells evade death signals by repressing the immune deficiency (IMD) pathway, which operates in parallel to Toll to control nuclear factor κB (NF-κB) activity and independently regulates JNK activity. 31402304 2019
CUI: C0022650
Disease: Kidney Calculi
Kidney Calculi
0.010 Biomarker disease BEFREE ROS and JNK pathways may contribute to CNP-induced cell injury and kidney stone formation. 29511793 2019
CUI: C0027073
Disease: Myofascial Pain Syndromes
Myofascial Pain Syndromes
0.010 AlteredExpression disease BEFREE Effect of transcutaneous electrical acupuncture point stimulation on expression of p-JNK in the dorsal root ganglion in a rat model of myofascial pain syndrome. 31219313 2019
CUI: C0027831
Disease: Neurofibromatosis 1
Neurofibromatosis 1
0.010 AlteredExpression disease BEFREE The DUSP inhibitor, BCI, diminished the survival of NF1-deleted Schwann cells and MPNST cell lines through activation of JNK. 30936125 2019